HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janine Doorduin Selected Research

Encephalitis (Encephalitis, Rasmussen)

5/2014Cerebral adenosine A₁ receptors are upregulated in rodent encephalitis.
1/2008PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Janine Doorduin Research Topics

Disease

27Neuroinflammatory Diseases
03/2024 - 01/2008
7Inflammation (Inflammations)
11/2021 - 01/2008
5Schizophrenia (Dementia Praecox)
11/2023 - 11/2012
4Mental Disorders (Mental Disorder)
01/2024 - 01/2015
4Anhedonia
03/2023 - 06/2020
4Herpes Simplex Encephalitis (Herpes Encephalitis)
05/2016 - 11/2009
3Infections
11/2023 - 01/2017
3Body Weight (Weight, Body)
01/2023 - 03/2008
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2008
3Alzheimer Disease (Alzheimer's Disease)
01/2021 - 03/2014
3Brain Diseases (Brain Disorder)
05/2019 - 03/2008
3Multiple Sclerosis
01/2017 - 01/2008
2Neurobehavioral Manifestations
11/2023 - 01/2022
2Psychotic Disorders (Schizoaffective Disorder)
07/2023 - 12/2015
2Weight Gain
01/2022 - 10/2016
2Nervous System Diseases (Neurological Disorders)
01/2021 - 01/2008
2Brain Neoplasms (Brain Tumor)
01/2020 - 01/2020
2Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2008
2Ischemia
01/2019 - 01/2018
2Neoplasms (Cancer)
01/2018 - 09/2008
2Disease Progression
01/2017 - 01/2008
2Major Depressive Disorder (Major Depressive Disorders)
01/2017 - 11/2012
2Bipolar Disorder (Manic Depressive Psychosis)
08/2014 - 11/2012
2Encephalitis (Encephalitis, Rasmussen)
05/2014 - 01/2008
1Hypothermia
03/2024
1Wounds and Injuries (Trauma)
07/2023
1Memory Disorders (Memory Loss)
10/2022
1Central Nervous System Diseases (CNS Diseases)
01/2022
1Fatigue
01/2022
1Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
01/2022
1Q Fever (Fever, Q)
01/2022
1Endotoxemia
01/2021
1Parkinsonian Disorders (Parkinsonism)
01/2020
1Cognitive Dysfunction
01/2020
1Stroke (Strokes)
01/2019
1Gliosis
01/2019
1Hypoxia (Hypoxemia)
01/2018
1Glioma (Gliomas)
01/2018
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2017
1Brain Concussion (Cerebral Concussion)
10/2016
1Autism Spectrum Disorder
01/2015
1Substance-Related Disorders (Drug Abuse)
01/2015

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2015
7LigandsIBA
03/2024 - 01/2008
6(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA
11/2023 - 10/2016
6PK 11195 (PK11195)IBA
01/2017 - 01/2008
5Glucose (Dextrose)FDA LinkGeneric
10/2022 - 10/2016
3salicylhydroxamic acid (SHAM)IBA
03/2024 - 05/2014
3CytokinesIBA
11/2023 - 11/2012
3Sucrose (Saccharose)IBA
03/2023 - 01/2022
3Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2020 - 01/2018
2Antipsychotic Agents (Antipsychotics)IBA
07/2023 - 10/2014
2Simvastatin (Zocor)FDA LinkGeneric
07/2023 - 12/2015
2CorticosteroneIBA
03/2023 - 01/2022
2Antidepressive Agents (Antidepressants)IBA
01/2022 - 01/2017
2EnzymesIBA
11/2021 - 01/2017
2isoquinolineIBA
01/2020 - 11/2009
2GABA-A Receptors (GABA(A) Receptor)IBA
11/2009 - 01/2008
1Cold Shock Proteins and PeptidesIBA
03/2024
1Estrogen ReceptorsIBA
01/2024
1Poly I-CIBA
11/2023
1Antiviral Agents (Antivirals)IBA
11/2023
1SynaptophysinIBA
11/2023
1Interleukin-10 (Interleukin 10)IBA
11/2023
1Valacyclovir (Valtrex)FDA LinkGeneric
11/2023
1Indicators and Reagents (Reagents)IBA
11/2023
1Silver Sulfadiazine (SSD)FDA LinkGeneric
07/2023
1KetamineFDA LinkGeneric
01/2022
1Histamine AgonistsIBA
01/2022
16- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA
01/2022
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2022
1Cyclooxygenase 1IBA
11/2021
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021
1Harmine (Telepathine)IBA
06/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2020
1Cholinergic Agents (Cholinergics)IBA
01/2020
1Haloperidol (Haldol)FDA LinkGeneric
01/2020
1fluorodopa F 18IBA
01/2020
1Dihydroxyphenylalanine (Dopa)IBA
01/2020
1RacloprideIBA
01/2020
1Deoxyglucose (2 Deoxy D glucose)IBA
07/2019
1Nerve Growth Factors (Neurotrophins)IBA
05/2019
1Therapeutic UsesIBA
01/2019
1Methionine (L-Methionine)FDA Link
01/2018
1CalciumIBA
01/2018
1Cysteine (L-Cysteine)FDA Link
01/2018
1Oxygen (Dioxygen)IBA
01/2018
1Propofol (Diprivan)FDA LinkGeneric
01/2018
1Flumazenil (Romazicon)FDA LinkGeneric
06/2017
1Serotonin (5 Hydroxytryptamine)IBA
01/2017
1Quinolinic AcidIBA
01/2017
1Fingolimod Hydrochloride (FTY720)FDA Link
01/2017
1(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA
05/2016
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2014
1Risperidone (Risperdal Consta)FDA LinkGeneric
10/2014

Therapy/Procedure

3Radiotherapy
01/2020 - 01/2018
2Therapeutics
01/2017 - 01/2008
2Aftercare (After-Treatment)
01/2017 - 03/2008
1Cardiopulmonary Bypass (Heart-Lung Bypass)
03/2024
1Intravenous Administration
01/2021